Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

18.1K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
18.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistic diversity of Bacteroides fragilis toxins and neutralization with single domain antibody.

Cell chemical biology·2026
Same author

Nanobody-based Pannexin1 channel inhibitors increase survival after cardiac ischemia/reperfusion.

Cell and tissue research·2025
Same author

Small but Mighty: Nanobodies in the Fight Against Infectious Diseases.

Biomolecules·2025
Same author

Evidence for a model of conformational change by the <i>Plasmodium falciparum</i> circumsporozoite protein during sporozoite development in the mosquito host through the use of camelid single-domain antibodies.

Infection and immunity·2025
Same author

Allosteric inhibition of trypanosomatid pyruvate kinases by a camelid single-domain antibody.

eLife·2025
Same author

In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting.

Antibodies (Basel, Switzerland)·2025
Same journal

RETRACTED: Zhang et al. A Novel Framework for Reconstruction and Imaging of Target Scattering Centers via Wide-Angle Incidence in Radar Networks. <i>Sensors</i> 2025, <i>25</i>, 6802.

Sensors (Basel, Switzerland)·2026
Same journal

Enhancing Unsupervised Multi-Source Domain Adaptation for Person Re-Identification via Mixture of Experts and Graph-Based Relation.

Sensors (Basel, Switzerland)·2026
Same journal

Development of an Instrumented Glove for Palmar Pressure Assessment in Kayakers.

Sensors (Basel, Switzerland)·2026
Same journal

Development and Experimental Validation of an Autonomous IoT-Based Monitoring System for Real-Time Water Quality Assessment in the Amazon River.

Sensors (Basel, Switzerland)·2026
Same journal

Semi-Supervised Adversarial Learning Framework for Controller Area Network Bus Intrusion Detection.

Sensors (Basel, Switzerland)·2026
Same journal

Smart Optimization Method for Safety Signs in Innovative Manufacturing Environments Integrating Industrial Field IoT Sensors and Knowledge Graphs.

Sensors (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

The Use of a &#946;-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
08:06

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

Published on: February 1, 2018

9.6K

Antibody Fragments as Probe in Biosensor Development.

Dirk Saerens1,2, Lieven Huang3,4,5,6, Kristien Bonroy7

  • 1Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussels, Belgium. dsaerens@vub.ac.be.

Sensors (Basel, Switzerland)
|November 23, 2016
PubMed
Summary
This summary is machine-generated.

Engineered antibody fragments offer superior biomarker detection in biosensors. These smaller, stable probes overcome limitations of full antibodies for enhanced assay development.

Keywords:
affinitydisplay technologyimmobilizationimmunoassay.stability

More Related Videos

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

21.6K
Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
10:44

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

Published on: November 13, 2017

6.9K

Related Experiment Videos

Last Updated: Mar 11, 2026

The Use of a &#946;-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
08:06

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions

Published on: February 1, 2018

9.6K
Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

21.6K
Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
10:44

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

Published on: November 13, 2017

6.9K

Area of Science:

  • Biotechnology
  • Biosensor Development
  • Molecular Recognition

Background:

  • Proteomic analyses yield numerous biomarkers requiring specific detection probes.
  • Antibodies are ideal for biosensors due to specificity but face immobilization and stability challenges.
  • Protein engineering offers solutions by creating smaller, more robust antibody formats.

Approach:

  • Reviewing antibody minimization strategies: Fab fragments, single-chain variable fragments (scFv), and single-domain antibody fragments (VH, VL, VHHs).
  • Discussing critical factors in assay development: probe size, immobilization tags, solid supports, and probe stability.
  • Exploring generic, one-step procedures for oriented coupling of antibody fragments onto biosensor substrates.

Key Points:

  • Engineered antibody fragments provide enhanced specificity and affinity for biomarker detection.
  • Minimization strategies address steric hindrance and improve stability compared to full antibodies.
  • Optimized immobilization techniques ensure directional coupling and generic application on biosensor surfaces.

Conclusions:

  • Designed antibody fragments are crucial for advancing biomarker analysis in biosensing.
  • Overcoming challenges associated with traditional antibodies leads to more sensitive and reliable biosensor assays.
  • Novel coupling methods facilitate efficient and specific probe integration for improved diagnostic tools.